SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
anti-tumor
Journals
9
1
Molecules (Basel, Switzerland)
2
International journal of biological macromolecules
3
Journal of medicinal chemistry
4
Carbohydrate polymers
5
Inorganic chemistry
6
Frontiers in bioengineering and biotechnology
7
Cancers
8
Frontiers in immunology
9
excli journal
Research Groups
0
No Research Group Connected
Bibliographies
46
1
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.
2
(Pers.): Food and Medicinal Plant with Potential In Vitro and In Vivo Anti-Cancer Activities.
3
Biomedical applications of laminarin.
4
Modification and application of polysaccharide from traditional Chinese medicine such as Dendrobium officinale.
5
Synthetic Approaches to the New Drugs Approved During 2018.
6
Effect of Mechanochemical Recrystallization on the Thermal Hysteresis of 1D Fe-triazole Spin Crossover Polymers.
7
Heteroleptic Tin(IV) Aminoalkoxides and Aminofluoroalkoxides as MOCVD Precursors for Undoped and F-Doped SnO Thin Films.
8
Reaction Mechanisms on [3 + 2] Cycloaddition of Azides with Metal Carbyne Complexes: Significant Effects of Aromaticity, Substituent, and Metal Center.
9
natural cures for breast cancer treatment
10
anti-tumor and anti-angiogenic ergosterols from ganoderma lucidum
11
anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of newcastle disease virus in vitro and in vivo
12
Mushroom-derived bioactive compounds pharmacological properties and cancer targeting: a holistic assessment.
13
Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
14
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
15
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
16
Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells.
17
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas.
18
Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases.
19
Anti-Tumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation.
20
The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease.
21
Biomimetic triphase composite scaffolds with antibacterial and anti-tumor potentials for bone repair
22
Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells.
23
Synthesis, characterization, photoluminescence, anti-tumor activity, DFT calculations and molecular docking with proteins of zinc(ii) halogen substituted terpyridine compounds.
24
Evaluation of Anti-Tumorigenic Effects of Diosmetin against Human Colon Cancer Xenografts in Athymic Nude Mice.
25
Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer.
26
Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy.
27
The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials.
28
promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies
29
eight-year preservation of knee function with radiographic healing phenomena after anti-tumor necrosis factor-α therapy for a severely erosive knee in a young patient with rheumatoid arthritis
30
influence of liposome forms of rhenium-platinum anti-tumor system on the proliferative activity of cancer cells
31
pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor dna vaccination
32
natural killer cell based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity
33
the ultimate goal of curative anti-cancer therapies : inducing an adaptive anti-tumor immune response
34
Phytochemical Screening and Determination of Antibacterial, Anti-Tumorigenic and DNA Protection Ability of Root Extracts of Saussurea Lappa
35
pharmacological modulation of anti-tumor immunity induced by oncolytic viruses
36
dysregulated expression of glycolipids in tumor cells: from negative modulator of anti-tumor immunity to promising targets for developing therapeutic agents
37
dysregulation of tgfβ1 activity in cancer and its influence on the quality of anti-tumor immunity
38
anti-tumor immunity in head and neck cancer: understanding the evidence, how tumors escape and immunotherapeutic approaches
39
isolation and assessment of the in vitro anti-tumor activity of smenothiazole a and b, chlorinated thiazole-containing peptide/polyketides from the caribbean sponge, smenospongia aurea
40
gold-gold sulfide nanoshell as a novel intensifier for anti-tumor effects of radiofrequency fields
41
radio-immunotherapy-induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses – preclinical evidence and ongoing clinical applications
42
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
43
Clarification of the phenotypic characteristics and anti-tumor activity of Hedyotis diffusa.
44
Authentication of the anti-tumor herb Baihuasheshecao with bioactive marker compounds and molecular sequences.
45
Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response.
46
Targeting of COPⅠ elicits CD8 T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma.